🇺🇸 FDA
Patent

US 11344626

Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use

granted A61KA61K2039/505A61K47/6803

Quick answer

US patent 11344626 (Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use) held by Sutro Biopharma, Inc. expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sutro Biopharma, Inc.
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K2039/505, A61K47/6803, A61K47/68031, A61K47/68033